on Medartis Holding AG (isin : CH0386200239)
Medartis Finalizes Full Acquisition of KeriMedical
Medartis Holding AG announced its acquisition of the remaining 53% stake in KeriMedical for CHF 99 million. With this move, Medartis enhances its position in joint replacement and broadens its surgeon network.
KeriMedical's TOUCH prosthesis, recently approved by the FDA, complements Medartis' hand and wrist product offerings. This acquisition supports Medartis’ strategic expansion, promising significant sales growth and a positive impact on EBITDA margins.
Both companies will maintain their distinct brands, with KeriMedical operating independently. Co-founders Dougal Bendjaballah and Bernard Prandi stay on KeriMedical's board, ensuring continuity and leveraging their entrepreneurial expertise. The acquisition is set to close in August 2025, pending customary conditions.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Medartis Holding AG news